Quick Answer
EXAGEN INC. reported Operating Income Loss of -$14.07 million for the year ending 2025.
- EXAGEN INC. showed a decrease of -3.2% in Operating Income Loss from 2024 to 2025.
- This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: -$1.13 million | Q1 2019: -$1.87 million | Q2 2019: -$2.41 million | Q3 2019: -$2.16 million | Q1 2020: -$5.22 million | Q2 2020: -$3.42 million | Q3 2020: -$3.79 million | Q1 2021: -$5.57 million | Q2 2021: -$5.74 million | Q3 2021: -$6.50 million | Q1 2022: -$9.68 million | Q2 2022: -$14.06 million | Q3 2022: -$7.82 million | Q1 2023: -$7.71 million | Q2 2023: -$4.92 million | Q3 2023: -$5.07 million | Q1 2024: -$3.00 million | Q2 2024: -$2.59 million | Q3 2024: -$4.66 million | Q1 2025: -$3.37 million | Q2 2025: -$2.63 million | Q3 2025: -$3.10 million.
- Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Operating Income Loss has declined by 188.3%.
- Historical annual values: Fiscal year 2025: -$14.07 million | Fiscal year 2024: -$13.64 million | Fiscal year 2023: -$22.84 million | Fiscal year 2022: -$46.05 million | Fiscal year 2021: -$24.07 million | Fiscal year 2020: -$15.19 million | Fiscal year 2019: -$9.30 million | Fiscal year 2018: -$4.88 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: